Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 4/20 | 0.58 |
| ▸ | BRD4 | O60885 | 15/20 | 0.47 |
| ▸ | BRD2 | P25440 | 13/20 | 0.47 |
| ▸ | BRD3 | Q15059 | 13/20 | 0.47 |
| ▸ | CREBBP | Q92793 | 5/20 | 0.47 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22900579 | 0.79 | BRD4 (0.53) | BRD4BRD2BRD3CREBBP | |
| SCHEMBL22900766 | 0.79 | QPCT (0.46) | QPCTBRD4BRD2BRD3CREBBP | |
| SCHEMBL22900604 | 0.78 | QPCT (0.58) | QPCTBRD4BRD2BRD3CREBBP | |
| SCHEMBL22900196 | 0.78 | QPCT (0.58) | QPCTBRD4BRD2BRD3CREBBP | |
| SCHEMBL22900602 | 0.78 | QPCT (0.58) | QPCTBRD4BRD2BRD3CREBBP | |
| SCHEMBL22900254 | 0.78 | QPCT (0.62) | QPCT | |
| SCHEMBL22900582 | 0.78 | BRD4 (0.63) | BRD4BRD2BRD3CREBBP | |
| SCHEMBL22900584 | 0.77 | BRD4 (0.73) | QPCTBRD4BRD2BRD3CREBBP | |
| SCHEMBL22900583 | 0.75 | BRD2 (0.47) | BRD4BRD2BRD3CREBBP | |
| SCHEMBL22900540 | 0.74 | BRD4 (0.42) | QPCTBRD4BRD2BRD3CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021009068-A1 | N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME | SCENIC IMMUNOLOGY B.V. (NL) | 2021-01-21 | — | — | WO | disclosed |